331 related articles for article (PubMed ID: 15717752)
1. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
Nieh S; Chen SF; Fu E; Jan CI; Lee WH
Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
[TBL] [Abstract][Full Text] [Related]
2. Expressions of human telomerase mRNA component (hTERC) and telomerase reverse transcriptase (hTERT) mRNA in effusion cytology.
Hiroi S; Nakanishi K; Kawai T
Diagn Cytopathol; 2003 Oct; 29(4):212-6. PubMed ID: 14506674
[TBL] [Abstract][Full Text] [Related]
3. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
[TBL] [Abstract][Full Text] [Related]
4. [Detection of human telomerase reverse transcriptase mRNA of cells in pleural fluid by two-step in situ hybridization using digoxin-labeled oligonucleotide probes].
Shu J; Sun GY; Liu AP; Liu J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):771-4. PubMed ID: 15257899
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
Shu J; Sun GY; Liu AP; Liu J
Clin Chim Acta; 2007 Jun; 381(2):131-5. PubMed ID: 17399696
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and hTERT mRNA expression in body fluids.
Yamamoto Y; Hirakawa E
Diagn Cytopathol; 2005 Mar; 32(3):167-70. PubMed ID: 15690332
[TBL] [Abstract][Full Text] [Related]
7. Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions.
Zendehrokh N; Rehnberg J; Dejmek A
Acta Cytol; 2007; 51(6):886-92. PubMed ID: 18077981
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions.
Rosolen DC; Kulikowski LD; Bottura G; Nascimento AM; Acencio M; Teixeira L; Vargas FS; Sales RK; Antonangelo L
Lung Cancer; 2013 Jun; 80(3):284-8. PubMed ID: 23453645
[TBL] [Abstract][Full Text] [Related]
9. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides.
Florentine BD; Sanchez B; Raza A; Frankel K; Martin SE; Kovacs B; Felix JC
Cancer; 1997 Oct; 81(5):299-308. PubMed ID: 9349518
[TBL] [Abstract][Full Text] [Related]
10. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effectiveness of malignancy detection in body fluid examination by the cytopathology and hematology laboratories.
Kendall B; Dunn C; Solanki P
Arch Pathol Lab Med; 1997 Sep; 121(9):976-9. PubMed ID: 9302931
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in benign and malignant cytologic fluids.
Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
14. Applications of the telomerase assay in peritoneal washing fluids.
Tseng CJ; Jain S; Hou HC; Liu W; Pao CC; Lin CT; Horng SG; Soong YK; Hsueh S
Gynecol Oncol; 2001 Jun; 81(3):420-3. PubMed ID: 11371132
[TBL] [Abstract][Full Text] [Related]
15. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
16. Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes.
Zendehrokh N; Dejmek A
Mod Pathol; 2005 Feb; 18(2):189-96. PubMed ID: 15389260
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis and cytopathology of body cavity fluids.
Stonesifer KJ; Xiang JH; Wilkinson EJ; Benson NA; Braylan RC
Acta Cytol; 1987; 31(2):125-30. PubMed ID: 3469844
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.
Hansson M; Zendehrokh N; Ohyashiki J; Ohyashiki K; Westman UB; Roos G; Dejmek A
Arch Pathol Lab Med; 2008 Dec; 132(12):1896-902. PubMed ID: 19061286
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization.
Heine B; Hummel M; Demel G; Stein H
J Pathol; 1998 Jun; 185(2):139-44. PubMed ID: 9713339
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions.
Nagel H; Schlott T; Schulz GM; Droese M
Diagn Mol Pathol; 2001 Mar; 10(1):60-5. PubMed ID: 11277397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
